Palantir Technologies, you see, has had a rather dazzling run. A positively stunning rise, in fact – over two thousand percent since 2023. One almost feels sorry for those who didn’t partake. The S&P 500, trailing along at a mere eighty percent, looks positively exhausted in comparison. It’s all been frightfully good for shareholders, naturally, fuelled by this current obsession with artificial intelligence. But, darling, let’s be realistic. At three hundred and forty billion in market cap, and trading at over two hundred times earnings? It’s simply… excessive. A bit vulgar, really.
Therefore, looking ahead – and one does look ahead, doesn’t one? – I suspect a rather significant correction is due. And two stocks that I venture to predict will not only survive, but positively thrive, and ultimately eclipse Palantir in value? Uber Technologies and Intuitive Surgical. Consider it a tip from someone who knows a good investment when they see one. Or, more accurately, when they foresee a rather predictable bubble bursting.
Uber Technologies
Uber, quite simply, has revolutionized getting about. It’s frightfully convenient, isn’t it? And while it’s already enjoyed considerable success, the truly remarkable thing is the sheer scope for further expansion. Plenty of markets remain unconquered, darling. Plus, the foray into robotaxis is rather clever. A partnership with WeRide to deploy 1,200 in the Middle East, and another with Alphabet’s Waymo here in the States… it’s all terribly forward-thinking. One approves.
From a mere seventeen billion in sales in 2021 to over fifty-two billion projected for 2025… it’s been a positively remarkable growth story. Trading at a sensible sixteen times earnings, and with a market cap of around one hundred and fifty billion – a mere trifle compared to Palantir’s extravagance – I’d wager it will overtake the data analytics firm within the next five years. A perfectly reasonable prediction, wouldn’t you say?
Intuitive Surgical
Intuitive Surgical, with a market cap of around one hundred and seventy-five billion, possesses a quiet confidence, a certain… solidity. Its da Vinci surgical system is, frankly, rather ingenious. Assisting surgeons with robotic precision… it’s terribly modern. And while its growth hasn’t been quite as explosive as Palantir’s, it’s been steadily, reliably… profitable. One prefers reliability, don’t you agree?
In 2025, the company generated over ten billion in revenue, with earnings around two point nine billion. Not bad, not bad at all. It’s still in the early stages of expanding its operations, and the potential is considerable.
With promising long-term prospects, this is another stock poised to surpass Palantir in value. At over sixty times earnings, it’s not exactly a bargain, of course. But its valuation is, shall we say, more… restrained. A perfectly sensible investment for those who appreciate a touch of elegance and a healthy dose of common sense. And frankly, darling, one always appreciates those.
Read More
- 21 Movies Filmed in Real Abandoned Locations
- 2025 Crypto Wallets: Secure, Smart, and Surprisingly Simple!
- 10 Hulu Originals You’re Missing Out On
- The 11 Elden Ring: Nightreign DLC features that would surprise and delight the biggest FromSoftware fans
- The 10 Most Beautiful Women in the World for 2026, According to the Golden Ratio
- 39th Developer Notes: 2.5th Anniversary Update
- 10 Underrated Films by Ben Mendelsohn You Must See
- ICP: $1 Crash or Moon Mission? 🚀💸
- 20 Films Where the Opening Credits Play Over a Single Continuous Shot
- Crypto’s Comeback? $5.5B Sell-Off Fails to Dampen Enthusiasm!
2026-02-11 17:33